A team of researchers from the University of Chicago, in collaboration with researchers from the University of Pittsburgh, ...

Researchers from Tokyo Metropolitan University have found that the motion of unlabeled cells can be used to tell whether they ...

BostonGene, a leader in AI-driven molecular and immune profiling that accelerates drug development and personalizes patient care, today announced that four abstracts have been selected for ...

A protein that stops cells from dividing in response to damage or stress could be a new biomarker or therapeutic target for ...

New research from the University of Georgia's School of Medicine promises to accelerate the development of personalized ...

Cell crowding causes high-grade breast cancer cells to become more invasive by activating a molecular switch that causes the cells to shrink and spread.

The global diagnostic exosome biomarkers market is poised for significant growth, with market demand projected to reach USD 196.8 million by the end of 2023. According to recent industry forecasts, ...